Mitochondrial Integrated Stress Response Activation Creates a Therapeutic Vulnerability to MCL-1 Inhibition in Acute Myeloid Leukemia
Lauren Brakefield-Laird(St. Jude Children's Research Hospital), Joseph T. Opferman(St. Jude Children's Research Hospital), Peter A. Hall(Population Health Research Institute), Denis Voronin(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Tresor O Mukiza(St. Jude Children's Research Hospital), Amit Budhraja(St. Jude Children's Research Hospital), Tristen Wright(St. Jude Children's Research Hospital), Stanley Pounds(St. Jude Children's Research Hospital), Sandi Radko-Juettner(St. Jude Children's Research Hospital), Yonghui Ni(St. Jude Children's Research Hospital), Yong‐Dong Wang(St. Jude Children's Research Hospital), Josi Lott(St. Jude Children's Research Hospital), Dixie Brewington(St. Jude Children's Research Hospital), Peter Vogel(Lexicon Pharmaceuticals (United States)), Oliver Grant-Chapman(St. Jude Children's Research Hospital), Jamila Moore(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
The p53 pathway
|The Journal of Pathology|1999|1.3k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853